Intellectual Property India Publishes Patent Application for 'Methods For Determination And Monitoring Of Xenotransplant Rejection By Measuring Nucleic Acids Or Proteins Derived From The Xenotransplant' Filed by Natera, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517043451 A) filed by Natera, Inc., San Carlos, U.S.A., on May 5, for 'methods for determination and monitoring of xenotransplant rejection by measuring nucleic acids or proteins derived from the xenotransplant.'

Inventor(s) include Constantin, Tudor Pompiliu; Zimmermann, Bernhard; Heilek, Gabrielle; and Wong, Swee Seong.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides methods for preparation and analysis of biological samples of xenotransplant recipients, wherein the methods comprise extracting fragmented or intact cell-free DNA, RNA (such as mRNA or miRNA), or protein derived from sample of the xenotransplant recipient, and measuring amounts of cell-free DNA, RNA (such as mRNA or miRNA), or protein derived from the xenotransplant enables assessment of xenotransplant rejection. The detection of the cell-free DNA, or RNA may be performed by preparing sequencing libraries and performing whole genome sequencing."

The patent application was internationally filed on Sept. 27, 2023, under International application No.PCT/US2023/033874.

Disclaimer: Curated by HT Syndication.